<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131138">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01930877</url>
  </required_header>
  <id_info>
    <org_study_id>H-32510</org_study_id>
    <nct_id>NCT01930877</nct_id>
  </id_info>
  <brief_title>Effect of Perioperative Intravenous Lidocaine on Postoperative Quality of Recovery in Patients Undergoing Spine Surgery</brief_title>
  <official_title>The Effect of Perioperative Lidocaine on Postoperative Quality of Recovery in Patients Undergoing Spine Surgery: A Randomized, Double - Blinded, Placebo Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute postoperative pain is an unpleasant, unwanted sensory and emotional experience for the
      patient. The investigators seek to determine if the addition of systemic lidocaine can
      improve the quality of recovery after spine surgery and reduce the requirement for opiate
      therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consented patients will be randomized to either saline group or lidocaine group. General
      anesthesia will be induced as it would normally be done in any patient undergoing spine
      surgery. Once the patient is positioned for the surgery bolus followed by the infusion of
      either the study drug or the placebo will be administered. The infusion will be stopped at
      the end of surgery and the patient will be transferred to the post anesthesia care unit.
      Post operative pain score will be evaluated for the first 24 hrs and also the amount of pain
      medications used will be recorded. At the end of 24 hours quality of recovery will be
      assessed using a qor-40 questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>At 24 hours after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative pain</measure>
    <time_frame>for the first 24 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Narcotic consumption</measure>
    <time_frame>24 hours after surgery</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous Lidocaine bolus of 1.5 mg/kg followed by infusion of 1.5 mg/kg/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline placebo infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Lidocaine iv bolus followed by infusion</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo (normal saline)</intervention_name>
    <description>Normal saline bolus followed by infusion</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients age 18-80 yrs;

          2. American Society of Anesthesiology Physical Status I, II or III; and

          3. Patients undergoing thoracic or lumbosacral spine surgeries with or without
             instrumentation via the posterior approach with planned admission to the post
             anesthesia care unit after surgery-

        Exclusion Criteria:

          1. Allergy to any of the study medications or anesthetic agents used in the study;

          2. American Society of Anesthesiology physical status IV;

          3. Spine surgery with the expected duration of surgery being more than 4 hours as
             determined by the attending surgeon;

          4. History of severe hepatic dysfunction with liver enzymes elevated to more than 3
             times the normal or International normalized ratio of more than 2 and renal
             dysfunction with GFR less than 60 ml/min

          5. History of previous spinal fusion or instrumentation;

          6. Diagnosis of cancer of the spine;

          7. History of surgery for abscess or osteomyelitis;

          8. History of cardiac dysrhythmia or heart block;

          9. History of chronic heroin or methadone use;

         10. Preoperative use of any systemic corticosteroid;

         11. History of seizure disorder; and

         12. Patient inability to properly describe postoperative pain to investigators (dementia,
             delirium, psychiatric disorder).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ben Taub General Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suman Rajagopalan, MD</last_name>
      <phone>713-873-3430</phone>
      <email>srajagop@bcm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Cecilia Browder</last_name>
      <phone>713-873-2860</phone>
      <email>cbrowder@bcm.tmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Suman Rajagopalan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 28, 2013</lastchanged_date>
  <firstreceived_date>August 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Suman Rajagopalan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>quality of recovery</keyword>
  <keyword>spine surgery</keyword>
  <keyword>intravenous lidocaine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
